0001127602-13-035625.txt : 20131226
0001127602-13-035625.hdr.sgml : 20131225
20131226190615
ACCESSION NUMBER: 0001127602-13-035625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131226
FILED AS OF DATE: 20131226
DATE AS OF CHANGE: 20131226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 131299325
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2013-12-26
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
CEO
Common Stock
2013-12-26
4
M
0
3833
34.56
A
3973
D
Common Stock
2013-12-26
4
S
0
3833
111.5897
D
140
D
Common Stock
2013-12-26
4
S
0
4998
111.9394
D
600678.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
800
112.5631
D
599878.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
100
113.62
D
599778.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
5046
111.935
D
594732.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
697
112.6883
D
594035.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
1632
111.9444
D
592403.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
215
112.7826
D
592188.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
4100
111.9244
D
588088.05
I
By Trusts
Common Stock
2013-12-26
4
S
0
560
112.5618
D
587528.05
I
By Trusts
Common Stock
166
I
By Spouse
Stock Options
34.56
2013-12-26
4
M
0
3833
0
D
2005-12-30
2015-12-30
Common Stock
3833
398658
D
This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
This transaction was executed in multiple trades at prices ranging from $111.36 to $111.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares were sold pursuant to pre-arranged 10b5-1 trading plans entered into by trusts beneficially owned by the reporting person and the reporting person's spouse.
This transaction was executed in multiple trades at prices ranging from $111.265 to $112.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.28 to $112.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $111.41 to $112.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.41 to $113.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $111.53 to $112.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.75 to $112.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $111.41 to $112.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $112.41 to $112.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2013-12-26